Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Amino Acids|April 30, 2008
Human S100A12: a novel key player in inflammation?Jens Pietzsch, Susan HoppmannThe International Journal of Biochemistry & Cell Biology|December 23, 2009
Scavenger receptors are associated with cellular interactions of S100A12 in vitro and in vivoSusan Hoppmann, Joerg Steinbach, Jens PietzschProtein Expression and Purification|November 28, 2007
Expression, purification and fluorine-18 radiolabeling of recombinant S100 proteins--potential probes for molecular imaging of receptor for advanced glycation endproducts (RAGE) in vivoSusan Hoppmann, Cathleen Haase, Susan Richter, et al.Current Pharmaceutical Design|January 26, 2012
Human serum albumin conjugated biomolecules for cancer molecular imagingMeng Yang, Susan Hoppmann, Luxi Chen, et al.Molecular Imaging and Biology|January 9, 2019
PET Imaging of HER2-Positive Tumors with Cu-64-Labeled Affibody MoleculesShibo Qi, Susan Hoppmann, Yingding Xu, et al.Bioconjugate Chemistry|February 9, 2011
Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targetingSusan Hoppmann, Zheng Miao, Shuanglong Liu, et al.Amino Acids|December 15, 2010
Expression, purification and fluorine-18 radiolabeling of recombinant S100A4: a potential probe for molecular imaging of receptor for advanced glycation endproducts in vivo?Susann Wolf, Cathleen Haase-Kohn, Jens Lenk, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|March 16, 2012
177Lu-DO3A-HSA-Z EGFR:1907: characterization as a potential radiopharmaceutical for radionuclide therapy of EGFR-expressing head and neck carcinomasSusan Hoppmann, Shibo Qi, Zheng Miao, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2013
Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessmentMatthias Glaser, Peter Iveson, Susan Hoppmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Positron emission tomography imaging with 18F-labeled ZHER2:2891 affibody for detection of HER2 expression and pharmacodynamic response to HER2-modulating therapiesSebastian Trousil, Susan Hoppmann, Quang-Dé Nguyen, et al.Pageof 2